Menu Search
Equities

China Health Technology Group Holding Co Ltd

CHBOF:PNK

China Health Technology Group Holding Co Ltd

Actions
  • Price (USD)0.005
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jan 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

China Health Technology Group Holding Co Ltd, formerly China Bozza Development Holdings Ltd, is a company principally engaged in the forestry management and ginseng business. The Company’s forestry management business is mainly engaged in the sales of timber logs harvested from forests. The Company’s ginseng business is mainly engaged in the planting and sales of compound hybridisation breed with traditional wild ginseng grown in the north or cold regions and other different varieties of ginseng. The Company mainly conducts businesses within the domestic market.

  • Revenue in HKD (TTM)59.14m
  • Net income in HKD207.36m
  • Incorporated2009
  • Employees27.00
  • Location
    China Health Technology Group Holding Co LtdRoom 4009, 40F, Rongchao Trading CentrNo. 4028 Jintian RoadFutian DistrictSHENZHEN ChinaCHN
  • Phone+86 75 582793080
  • Fax+86 75 582552379
  • Websitehttp://www.caflc.co/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		1069:HKG since
announced		Transaction
value
Liuba unty Jiashisen Traditional Chinese Medicine mprehensive Development Co LtdAnnounced07 Sep 202307 Sep 2023Announced-92.98%974.00k
Data delayed at least 15 minutes, as of May 20 2024 08:55 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.